Disruption of the plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites

Cellular Microbiology

Volumn 13, Issue 8, 2011, Pages 1250-1260

  Mikolajczak, Sebastian A ^a   Sacci Jr, John B ^b   De La Vega, Patricia ^c   Camargo, Nelly ^a   Vanbuskirk, Kelly ^a   Krzych, Urszula ^c   Cao, Jun ^d   Jacobs Lorena, Marcelo ^d   Cowman, Alan F ^e   Kappe, Stefan H I ^a,f  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Walter Reed Army Institute for Research   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CIRCUMSPOROZOITE PROTEIN; LIVER STAGE ANTIGEN 1; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; GAMETOCYTE; GENE DELETION; GENE LOCUS; LIVER CELL; MALARIA FALCIPARUM; MEROZOITE; MOUSE; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTIST LIFE CYCLE STAGE; SPOROZOITE; WILD TYPE;

ANIMALS; ANTIGENS, PROTOZOAN; CELL LINE; GENE DELETION; HEPATOCYTES; HUMANS; MEROZOITES; MICE; MICE, SCID; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SPOROZOITES;

MUS; PLASMODIUM FALCIPARUM;

EID: 79960423715     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2011.01617.x     Document Type: Article

References (38)

1. Aly, A.S., Vaughan, A.M., and Kappe, S.H. (2009) Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol 63: 195-221.
2. Bruder, J.T., Angov, E., Limbach, K.J., and Richie, T.L. (2010) Molecular vaccines for malaria. Hum Vaccin 6: 54-77.
3. Collins, W.E., Sullivan, J.S., Williams, A., Nace, D., Williams, T., Galland, G.G., and Barnwell, J.W. (2006) Aotus nancymaae as a potential model for the testing of anti-sporozoite and liver stage vaccines against Plasmodium falciparum. Am J Trop Med Hyg 74: 422-424.
4. Crabb, B.S., Rug, M., Gilberger, T.W., Thompson, J.K., Triglia, T., Maier, A.G., and Cowman, A.F. (2004) Transfection of the human malaria parasite Plasmodium falciparum. Methods Mol Biol 270: 263-276.
5. Cummings, J.F., Spring, M.D., Schwenk, R.J., Ockenhouse, C.F., Kester, K.E., Polhemus, M.E., etal. (2009) Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 28: 5135-5144.
6. Druilhe, P., Puebla, R.M., Miltgen, F., Perrin, L., and Gentilini, M. (1984) Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. Am J Trop Med Hyg 33: 336-341.
7. Fidock, D.A., Gras-Masse, H., Lepers, J.P., Brahimi, K., Benmohamed, L., Mellouk, S., etal. (1994) Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol 153: 190-204. [Published erratum appears in J Immunol 1994; 153: 5347.
8. Gruner, A.C., Brahimi, K., Letourneur, F., Renia, L., Eling, W., Snounou, G., and Druilhe, P. (2001) Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum. J Infect Dis 184: 892-897.
9. Guerin-Marchand, C., Druilhe, P., Galey, B., Londono, A., Patarapotikul, J., Beaudoin, R.L., etal. (1987) A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329: 164-167.
10. Hill, A.V., Elvin, J., Willis, A.C., Aidoo, M., Allsopp, C.E., Gotch, F.M., etal. (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434-439.
11. Hoffman, S.L., Goh, L.M., Luke, T.C., Schneider, I., Le, T.P., Doolan, D.L., etal. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185: 1155-1164.
12. Hollingdale, M.R., Leland, P., Leef, J.L., and Schwartz, A.L. (1983) Entry of Plasmodium berghei sporozoites into cultured cells, and their transformation into trophozoites. Am J Trop Med Hyg 32: 685-690.
13. Hollingdale, M.R., Aikawa, M., Atkinson, C.T., Ballou, W.R., Chen, G.X., Li, J., etal. (1990) Non-CS pre-erythrocytic protective antigens. Immunol Lett 25: 71-76.
14. John, C.C., Ouma, J.H., Sumba, P.O., Hollingdale, M.R., Kazura, J.W., and King, C.L. (2002) Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission. Am J Trop Med Hyg 66: 372-378.
15. John, C.C., Moormann, A.M., Sumba, P.O., Ofulla, A.V., Pregibon, D.C., and Kazura, J.W. (2004) Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria. Infect Immun 72: 5135-5142.
16. John, C.C., Tande, A.J., Moormann, A.M., Sumba, P.O., Lanar, D.E., Min, X.M., and Kazura, J.W. (2008) Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis 197: 519-526.
17. Kooij, T.W., Carlton, J.M., Bidwell, S.L., Hall, N., Ramesar, J., Janse, C.J., and Waters, A.P. (2005) A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes. PLoS Pathog 1: e44.
18. Liu, M.A. (2010) Immunologic basis of vaccine vectors. Immunity 33: 504-515.
19. Maier, A.G., Braks, J.A., Waters, A.P., and Cowman, A.F. (2006) Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. Mol Biochem Parasitol 150: 118-121.
20. Maier, A.G., Rug, M., O'Neill, M.T., Brown, M., Chakravorty, S., Szestak, T., etal. (2008) Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell 134: 48-61.
21. Mercer, D.F., Schiller, D.E., Elliott, J.F., Douglas, D.N., Hao, C., Rinfret, A., etal. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7: 927-933.
22. Nardin, E.H., Nussenzweig, V., Nussenzweig, R.S., Collins, W.E., Harinasuta, K.T., Tapchaisri, P., and Chomcharn, Y. (1982) Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med 156: 20-30.
23. Nicoll, W.S., Sacci, J.B., Rodolfo, C., Di Giacomo, G., Piacentini, M., Holland, Z.J.M., etal. (2011) Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase. Malaria J 10: 14.
24. Pei, Y., Tarun, A.S., Vaughan, A.M., Herman, R.W., Soliman, J.M., Erickson-Wayman, A., and Kappe, S.H. (2010) Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection. Mol Microbiol 75: 957-971.
25. Prudencio, M., Rodriguez, A., and Mota, M.M. (2006) The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol 4: 849-856.
26. Sacci, J.B., Jr, Alam, U., Douglas, D., Lewis, J., Tyrrell, D.L., Azad, A.F., and Kneteman, N.M. (2006) Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int J Parasitol 36: 353-360.
27. Sattabongkot, J., Yimamnuaychoke, N., Leelaudomlipi, S., Rasameesoraj, M., Jenwithisuk, R., Coleman, R.E., etal. (2006) Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg 74: 708-715.
28. van Schaijk, B.C., Janse, C.J., van Gemert, G.J., van Dijk, M.R., Gego, A., Franetich, J.F., etal. (2008) Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS ONE 3: e3549.
29. Silvie, O., Franetich, J.F., Charrin, S., Mueller, M.S., Siau, A., Bodescot, M., etal. (2004) A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem 279: 9490-9496.
30. Trager, W., and Jenson, J.B. (1978) Cultivation of malarial parasites. Nature 273: 621-622.
31. Tsuji, M., Mattei, D., Nussenzweig, R.S., Eichinger, D., and Zavala, F. (1994) Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res 80: 16-21.
32. Tsuji, M., Ishihara, C., Arai, S., Hiratai, R., and Azuma, I. (1995) Establishment of a SCID mouse model having circulating human red blood cells and a possible growth of Plasmodium falciparum in the mouse. Vaccine 13: 1389-1392.
33. VanBuskirk, K.M., O'Neill, M.T., De La Vega, P., Maier, A.G., Krzych, U., Williams, J., etal. (2009) Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci USA 106: 13004-13009.
34. Vaughan, A.M., Aly, A.S., and Kappe, S.H. (2008) Malaria parasite pre-erythrocytic stage infection: gliding and hiding. Cell Host Microbe 4: 209-218.
35. Vaughan, A.M., O'Neill, M.T., Tarun, A.S., Camargo, N., Phuong, T.M., Aly, A.S., etal. (2009) Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol 11: 506-520.
36. Vaughan, A.M., Wang, R., and Kappe, S.H. (2010) Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum Vaccin 6: 107-113.
37. Yang, C., Shi, Y.P., Udhayakumar, V., Alpers, M.P., Povoa, M.M., Hawley, W.A., etal. (1995) Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. Mol Biochem Parasitol 71: 291-294.
38. Zhu, J., and Hollingdale, M.R. (1991) Structure of Plasmodium falciparum liver stage antigen-1. Mol Biochem Parasitol 48: 223-226.